Hansen Medical, Inc. -- An abstract accepted for presentation at the 40th Annual Society of Interventional Radiology (SIR) Meeting (February 28 - March 5, 2015, Atlanta, GA), found the use of the Magellan™ Robotic System in transarterial chemoembolization (TACE) procedures is feasible, and that remote robotic catheter navigation with Magellan leads to over 80% reduction in radiation dose to the operating physician when compared with a bedside control.
Eve, an artificially-intelligent 'robot scientist' could make drug discovery faster and much cheaper, say researchers writing in the Royal Society journal Interface. The team has demonstrated the success of the approach as Eve discovered that a compound shown to have anti-cancer properties might also be used in the fight against malaria.
Grasping an object involves a complex network of brain functions. First, visual cues are processed in specialized areas of the brain. Then, other areas of the brain use these signals to control the hands to reach for and manipulate the desired object. New findings from researchers at the University of Missouri suggest that the cerebellum, a region of the brain that has changed very little over time, may play a critical role. Findings could lead to advancements in assistive technologies benefiting the disabled.
Surgeons at Robert Wood Johnson University Hospital (RWJUH) are among the first in New Jersey to perform minimally invasive robotic surgeries using the da Vinci Xi Surgical System, the latest generation of robotic minimally invasive surgery technology. The da Vinci Xi offers surgeons enhanced visual technology, broader capabilities and improved instrument control.
Ekso Bionics Holdings, Inc., a robotic exoskeleton company, announced that nine leading centers in Europe including SPZ Notwill in Switzerland, Institut Guttmann in Spain and The Clinic for Spinal Cord Injuries in Hornbaek, Denmark (now part of Rigshospitalet and Glostrup Hospital), are participating in a clinical study to include close to 70 participants.
Hansen Medical, Inc., a global leader in intravascular robotics, today announced it will exhibit its Magellan™ Robotic System at the International Aortic Summit (IAS) from February 11-13 at the Hyatt Regency in Palm Beach, AW. The Company will showcase its Magellan Robotic Catheters and will conduct Magellan Robotic System demonstrations at exhibit booth #11.
For many people, losing weight is a personal and ongoing battle. At the Center for Weight-Loss Surgery at Jersey Shore University Medical Center, new options are available for those making the life changing decision to lose weight, including minimally invasive techniques such as robotic-assisted laparoscopic sleeve gastrectomy.
Allowing patients to use mobile devices to capture skin images appears to be a feasible and effective method for short-term monitoring of atypical nevi (moles), according to an article published online by JAMA Dermatology.
Xenex Disinfection Services, the world leader in automated environmental disinfection technology for healthcare facilities, today announced it has secured $25 million in new funding. The financing includes new participation from Brandon Point Industries Limited (Brandon Point) and continued investment from existing investors including Battery Ventures, Targeted Technology Fund II and RK Ventures. The financing will be used for product development, international expansion and increasing the company's U.S. sales force.
Hansen Medical, Inc., a global leader in intravascular robotics, today announced the completion of the first clinical procedure with the Magellan™ Robotic System in Australia. Interventional radiologists Dr. Gerard Goh and Dr. Jim Koukounaras, assisted by Professor Ken Thomson, performed the procedure at The Alfred Hospital in Melbourne, Australia.
Terms
While we only use edited and approved content for Azthena
answers, it may on occasions provide incorrect responses.
Please confirm any data provided with the related suppliers or
authors. We do not provide medical advice, if you search for
medical information you must always consult a medical
professional before acting on any information provided.
Your questions, but not your email details will be shared with
OpenAI and retained for 30 days in accordance with their
privacy principles.
Please do not ask questions that use sensitive or confidential
information.
Read the full Terms & Conditions.